News | November 07, 2011

SNM Launches Web Site for Nuclear Medicine and Molecular Imaging Patients

November 7, 2011 – The Society of Nuclear Medicine (SNM) launched a new patient-focused website, discoverMI.org, to provide patients with information about nuclear medicine and molecular imaging and how it can play a critical role in the detection, treatment and management of diseases.

“Many times patients referred for a nuclear medicine or molecular imaging studies are nervous about what to expect,” said George Segall, M.D., SNM president. “By providing information and explaining the benefits of the study in an easy-to-understand format, we can offer them both help and support.”

The website focuses on three common disease areas: heart disease, cancer and brain disease. For each area, specific types of disease are detailed along with the various nuclear and molecular imaging procedures that are associated with each. General information on molecular imaging, an extensive glossary and a video library are also included on the site. Additionally, patients can stay up to date on the latest in molecular imaging news through Facebook and Twitter pages designed to complement the site.

DiscoverMI.org is supported by several patient advocacy groups that are a part of SNM’s Patient Advocacy Advisory Board (PAAB), including the Alzheimer’s Association, the American Thyroid Association, the Leukemia and Lymphoma Society, the Ovarian Cancer Alliance of Arizona, the Ovarian Cancer National Alliance, the American Heart Association, the Men’s Health Network and the Thyroid Cancer Survivors’ Association.

“I am thrilled that this comprehensive resource for patients is now available,” said Betsy de Parry, a member of SNM’s PAAB and author of Adventures in Cancer Land. Laurel Pracht, SNM PAAB member and patient advocate for the Ovarian Cancer National Alliance, added, “As a patient, it is critical to have access to user-friendly information about what is available for someone with your disease. The website provides information about both what is currently available in molecular imaging and how it may affect you.”

More than 16 million Americans undergo nuclear and molecular imaging and therapy procedures each year for a variety of conditions, including cancer, cardiovascular disease, neurological conditions and other physiological problems. Nuclear and molecular imaging procedures are an invaluable way to gather medical information that would otherwise be unavailable, require surgery or necessitate more expensive diagnostic tests.

For more information: www.snm.org

 

Related Content

New ASNC SPECT Imaging Guideline Addresses Advances in Myocardial Perfusion Imaging
News | SPECT Imaging | June 21, 2018
The American Society of Nuclear Cardiology (ASNC) has published an update to its 2010 guidelines for single photon...
FDA Clears New Imaging Functionalities for Biograph mCT PET/CT Systems
Technology | PET-CT | June 21, 2018
Siemens Healthineers will announce U.S. Food and Drug Administration (FDA) clearance of four new system features for...
PET/CT Changes Care for 59 Percent of Suspected Recurrent Prostate Cancer Cases
News | Prostate Cancer | June 13, 2018
A recently presented investigational clinical trial evaluated the impact of 18F fluciclovine positron emission...
Nuclear imaging scan showing very good tissue delineation. Scan performed on a Biograph Vision positron emission tomography/computed tomography (PET-CT) system from Siemens Healthineers.

Nuclear imaging scan showing very good tissue delineation. It offers crisp overall image quality and sharply delineates the muscle and fat planes, vertebral margins and end plates, billiary radicals, renal calyces, aortic wall and papillary muscles of the heart. Scan performed on a Biograph Vision positron emission tomography/computed tomography (PET-CT) system from Siemens Healthineers.

Technology | PET-CT | June 05, 2018
June 5, 2018 — The U.S.
Emerging Trends in Nuclear Medicine
Feature | Nuclear Imaging | June 04, 2018 | By Jeff Zagoudis
Nuclear imaging and its various modalities have long played an important role in the diagnosis and treatment of numer
PET Imaging Agent Could Provide Early Diagnosis of Rheumatoid Arthritis

Coronal 18F-FEDAC PET/CT section of a mouse with collagen-induced arthritis. (A) On day 23 and day 37, increased uptake is noted in the front and hind paws of this mouse with collagen-induced arthritis. (B) Predictive performance of day 23 18F-FEDAC uptake for the development of clinical arthritis. ROC = receiver operating characteristic; Sn = sensitivity; Sp = specificity. Credit: Seoul National University and Ewha Womans University, Seoul, South Korea

News | PET Imaging | May 17, 2018
A novel positron emission tomography (PET) tracer developed by Korean researchers can visualize joint inflammation and...
PET Imaging Shows Protein Clumping May Contribute to Heart Failure Development
News | PET Imaging | May 11, 2018
A team led by Johns Hopkins University Researchers has discovered that protein clumps appear to accumulate in the...
News | Radiopharmaceuticals and Tracers | May 09, 2018
Blue Earth Diagnostics signed an exclusive, worldwide agreement with Scintomics GmbH, Germany, a specialist in...
Novel PET Agent Could Help Guide Therapy for Brain Diseases

Rat brain 11C‐Me‐NB1 PET images (0‐60 min) superimposed on an MRI template. Credit: SD Krämer et al., ETH Zurich, Zurich, Switzerland

News | PET Imaging | April 10, 2018
Researchers have developed a new imaging agent that could help guide and assess treatments for people with various...
Overlay Init